CLOs on the Move

Moran Vista Assisted Living

www.moranvista.com

 
Moran Vista Assisted Living is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Conviva Care Solutions

Conviva Care Solutions is a management services organization that provides a variety of operational services for contracted medical practices. Those services include but are not limited to; practice operations, transportation, financial, coding, credentialing, human resources, legal, information technology, marketing and analytics. At Conviva Care Solutions, we focus on making it easier for physicians and clinicians to meet the needs of their patients and minimize the space between patients and clinicians, thereby maximizing the patient/clinician relationship.

ORCHA

DIGITAL HEALTH. UNLOCKED. Join the journey to transform the worlds health. Healthcare is in the middle of a digital revolution, yet the digital health market is unregulated. As the global leader in providing access to trusted digital health technologi...

Saint John's Health System

Saint John's Health System is a Anderson, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Queensland Health

Queensland Health is the states largest healthcare provider, committed to ensuring all Queenslanders have access to a range of public healthcare services aimed at achieving good health and well being.

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.